ANTIHYPERTENSIVE EFFICACY OF FIXED COMBINATION AZILSARTAN MEDOXOMIL/CHLORTHALIDONE IN PATIENTS WITH UNCONTROLLED ARTERIAL HYPERTENSION

被引:0
|
作者
Kobalava, Zh. D. [1 ]
Villevalde, S. V. [1 ]
Kulakov, V. V. [1 ]
机构
[1] RUDN Univ, Peoples Friendship Univ Russia, Moscow, Russia
关键词
azilsartan medoxomil; chlorthalidone; ambulatory blood pressure monitoring; efficacy; safety; BLOOD-PRESSURE; MEDOXOMIL; CHLORTHALIDONE; HYDROCHLOROTHIAZIDE; MANAGEMENT; VALSARTAN;
D O I
10.10087/cardio.2017.11.10049
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim. To study effects of a fixed azilsartan medoxomil/chlorthalidone combination (Edarbi Clo) on clinical, ambulatory and central blood pressure (BP) in patients with uncontrolled arterial hypertension (AH)). Materials and methods. Patients (n=25) with uncontrolled AH were given fixed azilsartan medoxomil/chlorthalidone combination (40/12.5 mg/day) for 4 weeks. After 4 weeks, in patients who did not achieve target BP levels the dose was increased up to 40/25 mg/day. Duration of the study was 12 weeks. Results. After 12 weeks of treatment 88% of patients achieved target clinical BP (< 140/90 mm Hg without diabetes, < 140/85 mm Hg with diabetes). According to 24-hour blood pressure monitoring (ABPM) decline of mean BP was 19.3/11.1 mm Hg, of mean daytime peripheral BP - 20.1/11.4 mm Hg, of mean nocturnal peripheral BP - 19.5/9.1 mm Hg, of central systolic (S), diastolic and pulse BP - 15.8, 10.1, 6.6 mm Hg, respectively. Target values of mean 24-hour BP were achieved in 40% of patients. Improvement of ABPM parameters led to normalization of the daily systolic BP index, associated with increase of the portion of "dippers" (from 60 to 64%) and reduction of that of "night-pickers" at the account of their transition into "non-dipper" and "dipper" categories. There were no adverse events either causing discontinuation after the first dose or serious. Conclusion. In patients with uncontrolled AP with/without diabetes therapy with fixed- azilsartan medoxomil/chlorthalidone combination was accompanied by pronounced antihypertensive effect (lowering of clinical, daily peripheral BP, improvement of the daily SBP profile). For the first time, the effectiveness of azilsartan medoxomil/chlorthalidone combination was demonstrated in relation to the central systolic, diastolic and pulse BP. Significant changes of parameters of carbohydrate or lipid metabolism, adverse events leading to drug discontinuation were not registered.
引用
收藏
页码:12 / 18
页数:7
相关论文
共 50 条
  • [1] Azilsartan Medoxomil/Chlorthalidone: A New Fixed-Dose Combination Antihypertensive
    Pierini, Danielle
    Anderson, Katherine Vogel
    ANNALS OF PHARMACOTHERAPY, 2013, 47 (05) : 694 - 703
  • [2] Efficacy of azilsartan medoxomil with chlorthalidone in hypertension
    Baker, William L.
    Nigro, Stefanie C.
    White, William B.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2014, 12 (07) : 791 - 798
  • [3] ACHIEVEMENT OF BLOOD PRESSURE TARGETS AND SAFETY OF AZILSARTAN MEDOXOMIL/CHLORTHALIDONE FIXED DOSE COMBINATION VERSUS AZILSARTAN MEDOXOMIL IN HYPERTENSIVE PATIENTS UNCONTROLLED ON MONOTHERAPY
    Juhasz, A.
    Collier, D.
    Caulfield, M.
    Agabiti-Rosei, E.
    Huang, P.
    Hisada, M.
    Zhao, L.
    Kupfer, S.
    JOURNAL OF HYPERTENSION, 2015, 33 : E8 - E8
  • [4] Antihypertensive Efficacy of Hydrochlorothiazide vs Chlorthalidone Combined with Azilsartan Medoxomil
    Bakris, George L.
    Sica, Domenic
    White, William B.
    Cushman, William C.
    Weber, Michael A.
    Handley, Alison
    Song, Eric
    Kupfer, Stuart
    AMERICAN JOURNAL OF MEDICINE, 2012, 125 (12): : 1229.e1 - 1229.e10
  • [5] Efficacy and safety of azilsartan medoxomil/chlortalidone fixed-dose combination in hypertensive patients uncontrolled on azilsartan medoxomil alone: A randomized trial
    Collier, David J.
    Juhasz, Attila
    Agabiti-Rosei, Enrico
    Lloyd, Eric
    Hisada, Michie
    Zhao, Lin
    Kupfer, Stuart
    Caulfield, Mark J.
    JOURNAL OF CLINICAL HYPERTENSION, 2018, 20 (10): : 1473 - 1484
  • [6] COST EFFECTIVENESS ANALYSIS OF AZILSARTAN MEDOXOMIL AND CHLORTHALIDONE FIXED DOSE COMBINATION THERAPY FOR TREATMENT OF HYPERTENSION
    Arikian, S. R.
    Corvino, F. A.
    Zivkovic, M.
    Hagan, M.
    VALUE IN HEALTH, 2012, 15 (04) : A121 - A121
  • [7] Population Pharmacokinetics and Exposure-Response of a Fixed-Dose Combination of Azilsartan Medoxomil and Chlorthalidone in Patients With Stage 2 Hypertension
    Tsai, Max C.
    Wu, Jingtao
    Kupfer, Stuart
    Vakilynejad, Majid
    JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 (08): : 988 - 998
  • [8] Azilsartan and Chlorthalidone-new Powerful Fixed dose Antihypertensive Combination
    Katsi, Vasiliki
    Athanasiadi, Eleni
    Tsioufis, Costas
    Tousoulis, Dimitris
    CURRENT HYPERTENSION REVIEWS, 2018, 14 (01) : 15 - 20
  • [9] Blood Pressure-Lowering Efficacy of the Fixed-Dose Combination of Azilsartan Medoxomil and Chlorthalidone: A Factorial Study
    Sica, Domenic
    Bakris, George L.
    White, William B.
    Weber, Michael A.
    Cushman, William C.
    Huang, Patrick
    Roberts, Andrew
    Kupfer, Stuart
    JOURNAL OF CLINICAL HYPERTENSION, 2012, 14 (05): : 284 - 292
  • [10] Clinical utility of azilsartan-chlorthalidone fixed combination in the management of hypertension
    Shuster, Jerrica E.
    Bleske, Barry E.
    Dorsch, Michael P.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2012, 8 : 381 - 387